(Q36447512)

14 August 2017

Efficacy of repeated high-dose hepatitis B vaccine (80 microg) in patients with chronic liver disease (English)

1 reference

14 August 2017

chronic liver disease

0 references

1 reference

Aziz A

1

1 reference

14 August 2017

Aziz S

2

1 reference

14 August 2017

Li DS

3

1 reference

14 August 2017

Murphy L

4

1 reference

14 August 2017

Leone N

5

1 reference

14 August 2017

Kennedy M

6

1 reference

14 August 2017

Dhillon S

7

1 reference

14 August 2017

Van Thiel DH

8

1 reference

14 August 2017

1 April 2006

1 reference

Journal of Viral Hepatitis

14 August 2017

1 reference

14 August 2017

13

1 reference

14 August 2017

4

1 reference

14 August 2017

217-221

1 reference

Implementation of vaccination in patients with cirrhosis

14 August 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2005.00674.X

Epidemiology and prevention of hepatitis B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2005.00674.X

Hepatitis C infection and the patient with end-stage renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2005.00674.X

Vaccination of patients with liver disease: who, when, and how.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2005.00674.X

Increased effective immunogenicity to high-dose and short-interval hepatitis B virus vaccination in individuals with chronic hepatitis without cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2005.00674.X

Decreased immunogenicity of recombinant hepatitis B vaccine in chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2005.00674.X

Efficacy of a high and accelerated dose of hepatitis B vaccine in alcoholic patients: a randomized clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2005.00674.X

A model to predict survival in patients with end-stage liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2005.00674.X

De novo hepatitis B infection after liver transplantation: source of disease, incidence, and impact

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2005.00674.X

Hepatitis B Vaccine in Health Care Personnel: Safety, lmmunogenicity, and Indicators of Efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2005.00674.X

Hepatitis B vaccine efficacy in patients with chronic liver disease by hepatitis C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2005.00674.X

10.1111/J.1365-2893.2005.00674.X

21 January 2018

Identifiers

DOI

1 reference

14 August 2017

1 reference